Papers
2
Total Citations
33
H-Index
2
About
Michael Au is a clinician-researcher whose work centers on head and neck oncology, with a particular focus on oropharyngeal squamous cell carcinoma and the functional outcomes of modern surgical interventions. His major contributions lie in evaluating the diagnostic and therapeutic benefits of transoral robotic surgery (TORS) and transoral laser microsurgery. In his most cited work (30 citations), Au demonstrated that TORS-assisted lingual tonsillectomy significantly improves the identification of hidden base-of-tongue carcinomas in patients presenting with head and neck carcinoma of unknown primary—a critical advancement that reduces diagnostic uncertainty and guides precise radiotherapy. More recently, his 2024 retrospective cohort study (3 citations) has broken new ground by examining return-to-work rates and self-reported swallowing function following TORS for early-stage oropharyngeal cancer, shifting the conversation from mere survival to quality-of-life metrics that matter to patients. Au’s research is notable for bridging surgical innovation with real-world patient recovery, offering evidence that helps clinicians counsel patients on both oncologic and functional expectations. His work continues to shape best practices in minimally invasive head and neck cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2